V
Veena Kapoor
Researcher at University of Pennsylvania
Publications - 64
Citations - 8939
Veena Kapoor is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Immunotherapy & Cytotoxic T cell. The author has an hindex of 39, co-authored 64 publications receiving 7589 citations.
Papers
More filters
Journal ArticleDOI
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Zvi G. Fridlender,Jing Sun,Samuel Kim,Veena Kapoor,Guanjun Cheng,Leona E. Ling,G. Scott Worthen,Steven M. Albelda +7 more
TL;DR: It is suggested that TGF-beta within the tumor microenvironment induces a population of TAN with a protumor phenotype, and depletion of these neutrophils significantly blunts antitumor effects of treatment and reduces CD8(+) T cell activation.
Journal ArticleDOI
Gemcitabine Selectively Eliminates Splenic Gr-1 + /CD11b + Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
TL;DR: The results suggest that gemcitabine may be a practical strategy for the reduction of myeloid suppressor cells and should be evaluated in conjunction with a variety of immunotherapy approaches.
Journal ArticleDOI
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T Cells Expressing a Mesothelin - Specific Chimeric Antibody Receptor
Edmund K. Moon,Carmine Carpenito,Jing Sun,Liang-Chuan S. Wang,Veena Kapoor,Jarrod D. Predina,Daniel J. Powell,James L. Riley,Carl H. June,Steven M. Albelda +9 more
TL;DR: CAR T cells bearing a functional chemokine receptor can overcome the inadequate tumor localization that limits conventional CAR targeting strategies and can significantly improve antitumor efficacy in vivo.
Journal ArticleDOI
Dynamic Actin Polymerization Drives T Cell Receptor–Induced Spreading: A Role for the Signal Transduction Adaptor LAT
TL;DR: It is shown that TCR engagement triggers the formation and expansion of contacts bounded by continuously remodeled actin-rich rings, and the maintenance of the resulting contact requires sustained calcium influxes, an intact microtubule cytoskeleton, and functional LAT.
Journal ArticleDOI
Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.
Liang-Chuan S. Wang,Albert C. Lo,John Scholler,Jing Sun,Rajrupa S. Majumdar,Veena Kapoor,Michael Antzis,Cody E. Cotner,Laura A. Johnson,Amy C. Durham,Charalambos C. Solomides,Carl H. June,Ellen Puré,Steven M. Albelda +13 more
TL;DR: It is shown that inhibiting tumor growth by targeting tumor stroma with adoptively transferred CAR T cells directed to FAP can be safe and effective, suggesting that further clinical development of anti-human FAP-CAR is warranted.